Pfizer, FDA Updating Pregnancy Caution On Zoloft Label
Pfizer Inc. is in talks with the U.S. Food and Drug Administration to update the label on its antidepressant Zoloft to acknowledge studies showing increased heart defect risks in children whose...To view the full article, register now.
Already a subscriber? Click here to view full article